Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for Prevention of Amphotericin B-Induced Electrolyte Abnormalities
NCT01843309Phase 4Terminated
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- May 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in hypokalemia, hypomagnesemia, acute kidney injury (AKI), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Started May 2013; status: terminated.
02
Drugs
spironolactone
03
Conditions
hypokalemiahypomagnesemiaacute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01843309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01843309.